India’s specialty chemical manufacturers are facing a more demanding fiscal scenario in 2026-27, with revenue growth projections moderating to approximately 6 per cent, down from the 8 per cent growth consistently achieved over previous two years. Recent Crisil Ratings data show, while domestic demand remains a steady for the industry, the combination of subdued international procurement and persistent volatility in crude-linked input costs is putting significant downward pressure on profit. Export volumes, which typically command superior margins, have been hindered by ongoing supply chain disruptions and a cautious appetite among overseas buyers. Operating margins are expected to fall to a range of 14-14.5 per cent, down from 16 per cent in the previous fiscal year.